Multidisciplinary Management of Gastric Cancer

被引：13

作者：

Misleh, Jamal G. ^{[1
]}

Santoro, Peter ^{[2
]}

Strasser, Jonathon F.

Bennett, Joseph J. ^{[2
]}

机构：

[1] Christiana Care Hosp, Helen F Graham Canc Ctr, Med Oncol Hematol Consultants, Dept Med Oncol, Newark, DE 19713 USA

[2] Christiana Care Hosp, Helen F Graham Canc Ctr, Dept Surg, 4701 Ogletown Stanton Rd,Suite 4000, Newark, DE 19713 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2013年 / 22卷 / 02期

关键词：

Gastric cancer; D2; lymphadenectomy; Multidisciplinary; Adjuvant; Chemotherapy; LYMPH-NODE DISSECTION; PHASE-III TRIAL; MARUYAMA INDEX SURGERY; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; GASTROESOPHAGEAL ADENOCARCINOMA; CURATIVE RESECTION; PLUS CISPLATIN; PERIOPERATIVE CHEMOTHERAPY; 1ST-LINE TREATMENT;

D O I：

10.1016/j.soc.2012.12.013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Multidisciplinary Management of Gastric Cancer Jamal G. Misleh, Peter Santoro, Jonathon F. Strasser, and Joseph J. Bennett Treatment of gastric cancer involves a multidisciplinary approach to achieve long-term outcome, including surgery, chemotherapy, and radiation therapy. Most patients present with advanced disease and are not candidates for a curative approach. Palliative chemotherapy is recommended for symptom control and for short-term advances in survival. Surgery combined with different chemotherapy and chemoradiation options improves survival. Initial studies focused on adjuvant chemoradiation and showed improved survival. More recent trials have demonstrated that perioperative chemotherapy before and after surgery provides a survival advantage. Such an approach may also downstage marginal patients who can then be selected to undergo curative resection and complete adjuvant chemotherapy.

引用

页码：247 / 264

页数：18

共 76 条

[11] RANDOMIZED COMPARISON OF MORBIDITY AFTER D1 AND D2 DISSECTION FOR GASTRIC-CANCER IN 996 DUTCH PATIENTS [J].

BONENKAMP, JJ ;

SONGUN, I ;

HERMANS, J ;

SASAKO, M ;

WELVAART, K ;

PLUKKER, JTM ;

VANELK, P ;

OBERTOP, H ;

GOUMA, DJ ;

TAAT, CW ;

VANLANSCHOT, J ;

MEYER, S ;

DEGRAAF, PW ;

VONMEYENFELDT, MF ;

TILANUS, H ;

VANDEVELDE, CJH .

LANCET, 1995, 345 (8952) :745-748

[12] Extended lymph-node dissection for gastric cancer [J].

Bonenkamp, JJ ;

Hermans, J ;

Sasako, M ;

van de Velde, CJH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) :908-914

[13] Subtotal versus total gastrectomy for gastric cancer -: Five-year survival rates in a multicenter randomized Italian trial [J].

Bozzetti, F ;

Marubini, E ;

Bonfanti, G ;

Miceli, R ;

Piano, C ;

Gennari, L .

ANNALS OF SURGERY, 1999, 230 (02) :170-178

[14] Laparoscopy in the management of gastric adenocarcinoma [J].

Burke, EC ;

Karpeh, MS ;

Conlon, KC ;

Brennan, MF .

ANNALS OF SURGERY, 1997, 225 (03) :262-267

[15] Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [J].

Cascinu, Stefano ;

Labianca, Roberto ;

Barone, Carlo ;

Santoro, Armando ;

Carnaghi, Carlo ;

Cassano, Alessandra ;

Beretta, Giordano D. ;

Catalano, Vincenzo ;

Bertetto, Oscar ;

Barni, Sandro ;

Frontini, Luciano ;

Aitini, Enrico ;

Rota, Silvia ;

Torri, Valter ;

Floriani, Irene .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (08) :601-607

[16] A RANDOMIZED TRIAL COMPARING ADJUVANT FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN WITH NO TREATMENT IN OPERABLE GASTRIC-CANCER [J].

COOMBES, RC ;

SCHEIN, PS ;

CHILVERS, CED ;

WILS, J ;

BERETTA, G ;

BLISS, JM ;

RUTTEN, A ;

AMADORI, D ;

CORTESFUNES, H ;

VILLARGRIMALT, A ;

MCARDLE, C ;

RAUSCHECKER, HF ;

BOVEN, E ;

VASSILOPOULOS, P ;

WELVAART, K ;

FERREIRA, EP ;

WIIG, J ;

GISSELBRECHT, C ;

ROUGIER, P ;

WOODS, EMA .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1362-1369

[17] A COMPARISON OF 3 CHEMOTHERAPEUTIC REGIMENS IN THE TREATMENT OF ADVANCED PANCREATIC AND GASTRIC-CARCINOMA - FLUOROURACIL VS FLUOROURACIL AND DOXORUBICIN VS FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN [J].

CULLINAN, SA ;

MOERTEL, CG ;

FLEMING, TR ;

RUBIN, JR ;

KROOK, JE ;

EVERSON, LK ;

WINDSCHITL, HE ;

TWITO, DI ;

MARSCHKE, RF ;

FOLEY, JF ;

PFEIFLE, DM ;

BARLOW, JF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (14) :2061-2067

[18] Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].

Cunningham, David ;

Starling, Naureen ;

Rao, Sheela ;

Iveson, Timothy ;

Nicolson, Marianne ;

Coxon, Fareeda ;

Middleton, Gary ;

Daniel, Francis ;

Oates, Jacqueline ;

Norman, Andrew Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46

[19] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].

Cunningham, David ;

Allum, William H. ;

Stenning, Sally P. ;

Thompson, Jeremy N. ;

Van de Velde, Cornelis J. H. ;

Nicolson, Marianne ;

Scarffe, J. Howard ;

Lofts, Fiona J. ;

Falk, Stephen J. ;

Iveson, Timothy J. ;

Smith, David B. ;

Langley, Ruth E. ;

Verma, Monica ;

Weeden, Simon ;

Chua, Yu Jo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20

[20] Postoperative morbidity and mortality after D-1 and D-2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial [J].

Cuschieri, A ;

Fayers, P ;

Fielding, J ;

Craven, J ;

Bancewicz, J ;

Joypaul, V ;

Cook, P .

LANCET, 1996, 347 (9007) :995-999

← 1 2 3 4 5 6 7 8 →